source
- FDA clears Freenome's SimpleScreen CRC blood test, Abbott to market it in U.S.The U.S. Food and Drug Administration has given clearance to Freenome’s SimpleScreen CRC, a blood-based test for colorectal cancer. Abbott will be the exclusive U.S. marketer and will pay Freenome…
- Claris Biotherapeutics raises $118M Series B to advance corneal stem-cell eye dropClaris Biotherapeutics announced a $118 million Series B financing round led by Novo Holdings and supported by several venture firms. The funding will be used to move its lead candidate, CSB-001, i…